Chemours falls as EPA's rollback of refrigerant rule raises oversupply concerns
Source: SeekingAlpha
2026-05-21 13:44:29 ET
More on Chemours
- The Chemours Company 2026 Q1 - Results - Earnings Call Presentation
- The Chemours Company (CC) Q1 2026 Earnings Call Transcript
- Chemours: Thesis Materialization In 2026 (Rating Downgrade)
- Chemours expects Q2 adjusted EBITDA of $220M-$250M as it targets net leverage below 3.8x by year-end 2026
- Chemours declines 13% after mixed quarter, flags higher financing costs
Read the full article on Seeking Alpha
For further details see:
Chemours falls as EPA's rollback of refrigerant rule raises oversupply concerns
Chemours Company (The)
NASDAQ: CC
CC Trading
-4.99% G/L:
$20.775 Last:
980,854 Volume:
$21.37 Open:
CC Latest News
June 03, 2026 04:00:00 pm
Immunotherapy Innovations: Increasing Survival in Metastatic Breast Cancer
